Cargando…
Role of LKB1 in lung cancer development
Three phenotypically related genetic syndromes and their lesions (LKB1, PTEN, and TSC1/2) are identified as frequently altered in lung cancer. LKB1, a kinase inactivated in 30% of lung cancers, is discussed in this review. Loss of LKB1 regulation often coincident with KRAS activation allows for unch...
Autores principales: | Makowski, L, Hayes, D N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528145/ https://www.ncbi.nlm.nih.gov/pubmed/18728656 http://dx.doi.org/10.1038/sj.bjc.6604515 |
Ejemplares similares
-
Targeting LKB1 in cancer – exposing and exploiting vulnerabilities
por: Momcilovic, M, et al.
Publicado: (2015) -
At the crossroads: AMP-activated kinase and the LKB1 tumor suppressor link cell proliferation to metabolic regulation
por: Kyriakis, John M
Publicado: (2003) -
Progress in treatment of small-cell lung cancer: role of CPT-11
por: Saijo, N
Publicado: (2003) -
Integrins: roles in cancer development and as treatment targets
por: Jin, H, et al.
Publicado: (2004) -
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
por: Murukesh, N, et al.
Publicado: (2010)